Rohto Pharmaceutical Co (MEX:4527N) Research & Development: MXN0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4527N Rohto Pharmaceutical Co Ltd MEX:4527N
92 GF Score
Price MXN305.75
GF Value MXN428.89
! 2 Warning Signs
View Full Analysis

What is Rohto Pharmaceutical Co Research & Development?

Rohto Pharmaceutical Co MEX:4527N 92 Research & Development is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:4527N with a GF Score™ of 92/100 and a GF Value™ of MXN428.89. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Rohto Pharmaceutical Co's Research & Development for the three months ended in Mar. 2026 was MXN0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was MXN0 Mil.

Rohto Pharmaceutical Co  (MEX:4527N) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Rohto Pharmaceutical Co Research & Development Related Terms

Rohto Pharmaceutical Co Research & Development Historical Data

* Premium members only.

The historical data trend for Rohto Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rohto Pharmaceutical Co Research & Development Chart

Rohto Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,467.58 1,492.15 1,483.29 2,046.68 1,559.94

Rohto Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:4527N
92GF Score
Rohto Pharmaceutical Co Ltd MEX:4527N
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rohto Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN0 Mil mean?
Rohto Pharmaceutical Co (MEX:4527N) has a Research & Development of MXN0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Rohto Pharmaceutical Co and its competitors.
Is Rohto Pharmaceutical Co's Research & Development too high?
Rohto Pharmaceutical Co's current Research & Development is MXN0 Mil. Overall, Rohto Pharmaceutical Co has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Rohto Pharmaceutical Co's Research & Development compare to PG and CL?
Rohto Pharmaceutical Co's Research & Development of MXN0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Rohto Pharmaceutical Co and its competitors. Rohto Pharmaceutical Co's current Research & Development is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rohto Pharmaceutical Co stock overvalued right now?
Rohto Pharmaceutical Co (MEX:4527N) has a current Research & Development of MXN0 Mil. The stock's GF Value™ is MXN428.89, compared to a current price of MXN305.75 — trading 28.7% below its estimated fair value. The current Research & Development is MXN0 Mil. Rohto Pharmaceutical Co's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Rohto Pharmaceutical Co (MEX:4527N), the current Research & Development is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rohto Pharmaceutical Co (MEX:4527N) Overvalued in 2026?

Based on GuruFocus' analysis, Rohto Pharmaceutical Co stock appears to be undervalued. The current stock price of MXN305.75 is trading 28.7% below its estimated GF Value™ of MXN428.89.

Key valuation signals for MEX:4527N:

  • Research & Development: MXN0 Mil
  • GF Value™: MXN428.89 vs. price of MXN305.75 (28.7% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the MEX:4527N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rohto Pharmaceutical Co Business Description

Address 1-8-1 Tatsuminishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
92GF Score

Get the complete analysis for MEX:4527N

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN305.75
Price
MXN428.89
GF Value